Our people
  • 13_Mark Bakker.png
    Mark Bakker
    Director

    Benelux / Private Equity

    Mark Bakker

    Director
    Benelux / Private Equity
    Business & Technology Services, Healthcare  

    Mark is a Director based in Amsterdam. He joined 3i in 2008 and has also worked in 3i's New York office.

    As a member of the deal team, he was involved in the investment in Magnitude, a data management software company, and ICE, a global travel & loyalty business. Mark was also involved in the buyout, portfolio management and exit of Element Materials Technology, a global testing business, as well as 3i’s investments in Refresco and KINOLT and several add-on investments in the Netherlands for Onemed. Mark led the sale of German automotive supplier Hilite International to AVICEM from China. He is a Board member of Magnitude.

    Previously Mark worked at ABN AMRO Corporate Development and ABN AMRO Global Clients. During his time at ABN AMRO, he was involved in the sale of ABN AMRO to a consortium of Fortis, RBS and Santander. Mark started his career at Heineken where he executed a commercial excellence program in Seoul, South Korea.

    Mark holds a Masters degree in Technology Management from the University of Groningen, the Netherlands.

    3i office address

    Cornelis Schuytstraat 72
    1071 JL Amsterdam
    0031 / 20 3057444
    0031 / 20 3057455

     

    Investments

  • 15_Guillaume Basquin.png
    Guillaume Basquin
    Director

    France / Private Equity

    Guillaume Basquin

    Director
    France / Private Equity
    Consumer, Healthcare  

    Guillaume is a Director in the French Private Equity team and has been based in Paris since 2006.

    His investment track record includes the investments and exits of the leading French online broker Empruntis; Cerenicimo, a distribution platform for speciality rental real estate investment products; Labco, the European medical diagnostic network; WFCI, the leading player in the GSSA market (cargo freight management); Loxam, the European leader in rental equipment for the construction industry; the current investment in Havea Group, a European leader in the natural consumer healthcare industry; the current investment in Evernex, a leading international provider of third party maintenance of critical IT infrastructure; BioProcessing, a Europe and US single-use technology platform serving the biopharmaceutical sector; and the current investment in Ionisos, a leading owner and operator of cold sterilisation facilities servicing the medical, pharmaceutical and cosmetics industries. Guillaume is currently on the boards of Havea and Evernex.

    Guillaume graduated from the French engineering school ENSAM and has a Masters in Finance from ESCP. Before joining 3i, he worked in the transaction services department of PwC (providing due diligence services for PE firms and corporates) and in the leverage finance team of the French bank Société Générale in New York.

    3i office address

    29 rue de Berri,
    75008 Paris
    + 33 1 73 15 11 00
  • Jake Behrman_bio.png (2)
    Jake Behrman
    Senior Associate

    North America / Private Equity

    Jake Behrman

    Senior Associate
    North America / Private Equity
    Healthcare  

    Jake joined 3i in 2018 as a member of its North American Private Equity team based in New York. Jake has since been involved in 3i’s investment in Cirtec Medical.

    Prior to joining 3i, Jake worked as an Associate at Metalmark Capital, a middle-market private equity firm currently investing out of a $2.5 billion fund. While at Metalmark, he helped execute a number of platform investments and transformative portfolio company acquisitions. Jake was previously an Analyst in the Global Healthcare Investment Banking Group at Morgan Stanley.

    Jake graduated from the University of Michigan’s Stephen M. Ross School of Business with High Distinction.

    3i office address

    One Grand Central Place
    60 E. 42nd St, Ste 4100
    New York, NY 10165
    +1 (212) 848 1400
    +1 (212) 848 1401

     

    Investments
    Cirtec Medical

  • 43_Rowena Gracey.png
    Rowena Gracey
    Director

    UK / Private Equity

    Rowena Gracey

    Director
    UK / Private Equity
    Consumer, Healthcare  

    Rowena joined 3i in 2007 and is based in London, focusing on originating, executing and representing 3i on the Boards of Private Equity investments. She has been involved in 3i's investments in Audley Travel, Aspen Pumps and Phibro Animal Health, and the sale of Centrul Medical Unirea to Advent International. Rowena currently sits on the Board of Audley Travel.

    Previously, Rowena worked for venture capital firm Scottish Equity Partners in London, and for boutique funds management group Quest Asset Partners in Sydney.

    Rowena holds a Bachelor of Advanced Science/Commerce degree from the University of Sydney, Australia and spent one year of her degree on exchange at Royal Holloway, University of London.

    3i office address

    16 Palace Street
    London SW1E 5JD
    +44 (0) 20 7975 3131
    +44 (0) 20 7975 3232

     

    Investments

  • Jacques-Henry_Grislain.jpg
    Jacques-Henry Grislain
    Senior Associate

    France / Private Equity

    Jacques-Henry Grislain

    Senior Associate
    France / Private Equity
    Healthcare  

    Jacques-Henry is a Senior Associate in the French Private Equity team and joined 3i in 2018. Since joining, he has worked from the New York office on the merger between International Cruise & Excursion ("ICE") and SOR Technology, two global providers of technology-based, travel-related loyalty solutions. He has also worked on the acquisition of Evernex, a leading provider of third party maintenance services for data centre infrastructure. He is a member of the healthcare origination team within 3i.

    Prior to joining 3i, Jacques-Henry was co-founder and CEO of Cambridge Crops Inc., a biotechnology company based in Boston, Massachusetts, which he successfully sold in summer 2018.

    He began his career in private equity at Astorg, spending four years in the Paris team where he completed several investments in the healthcare and industrial sectors and sat on the board of a leading European specialty pharmaceutical company focused on critical care. 

    Jacques-Henry is a graduate from EDHEC Business School and the Massachusetts Institute of Technology (MIT).

    3i office address

    29 rue de Berri,
    75008 Paris
    + 33 1 73 15 11 00
  • 56_Rahul Lulla.png
    Rahul Lulla
    Director

    North America / Private Equity

    Rahul Lulla

    Director
    North America / Private Equity
    Business & Technology Services, Industrial, Healthcare  

    Rahul Lulla joined 3i in 2012 as a member of the North American Private Equity team.

    Rahul focuses on Business & Technology Services, Healthcare and Industrial and has been involved in 3i’s investments in Mold-Masters, Quintiles, TouchTunes, Q Holdings, Dynatect Manufacturing and I.C.E. He currently sits on the Boards of Dynatect Manufacturing and I.C.E.

    Previously, Rahul worked at Monitor Clipper Partners in Boston, where he focused on investments in business services and consumer. Prior to this, Rahul worked at Credit Suisse in New York where he was a member of the Investment Banking Division’s Healthcare Group.

    Rahul received a BA in Economics and Mathematics with Honors from Vassar College, and an MBA with Honors from Columbia Business School.

    3i office address

    One Grand Central Place
    60 E. 42nd St, Ste 4100
    New York, NY 10165
    +1 (212) 848 1400
    +1 (212) 848 1401

     

    Investments

  • Severin Matten - 1.jpg
    Severin Matten
    Associate Director

    Germany / Private Equity

    Severin Matten

    Associate Director
    Germany / Private Equity
    Business & Technology Services, Healthcare  

    Severin joined 3i in 2014 and is an Associate Director in the German Private Equity team. He covers the healthcare sector for German-speaking Europe.

    He was a deal team member on 3i’s investments in Christ and Formel D. As a core member of the deal team, he led the successful sale of ATESTEO, the leading independent provider for drivetrain testing services.

    Before joining 3i, Severin spent two years at UBS Investment Bank covering the German-speaking region. He also worked as Business Development Manager for a portfolio company of HAL Investments, which is active in the sale of medical aids.

    Severin graduated with a CEMS Master in International Management from the Rotterdam School of Management (the Netherlands) and HEC Paris (France).

    3i office address

    OpernTurm
    Bockenheimer Landstraße 2-4
    60306 Frankfurt am Main
    +49 69 710000 0
    +49 69 710000 113

     

    Investments

  • 69_Nikhil Patel.png
    Nikhil Patel
    Director

    North America / Private Equity

    Nikhil Patel

    Director
    North America / Private Equity
    Healthcare  

    Nikhil joined 3i in 2016 in the New York office and is a member of 3i's Healthcare sector coverage team. He participates in all elements of the investment process, including industry segment analysis, identification and screening of new opportunities, due diligence, transaction structuring, financing and execution. He currently sits on the Boards of Q Holding and Cirtec Medical.

    Prior to joining 3i, Nikhil was a Vice President at Chicago Pacific Founders, where he was an integral member of a debut middle market private equity fund and participated in the acquisition of three portfolio companies. Prior to joining CPF, Nikhil was a Senior Associate at Water Street Healthcare Partners, a mid-market private equity firm with approximately $2 billion of capital under management. While at Water Street, he helped execute a number of platform investments and successful portfolio company exits. Nikhil was previously an Analyst in the Global Healthcare Investment Banking division of UBS Investment Bank.

    Nikhil graduated from New York University’s Leonard Stern School of Business with Honors.

    3i office address

    One Grand Central Place
    60 E. 42nd St, Ste 4100
    New York, NY 10165
    +1 (212) 848 1400
    +1 (212) 848 1401

     

    Investments

  • 73_Richard Relyea.png
    Richard Relyea
    Partner, Managing Director

    North America / Private Equity

    Richard Relyea

    Partner, Managing Director
    North America / Private Equity
    Industrial, Healthcare  

    Richard joined 3i in 2007 and is co-Head of 3i’s North American Private Equity team.

    He focuses on Healthcare and Industrials and has been involved in 3i’s investments in Mold-Masters, Quintiles, Q Holding, Dynatect Manufacturing, Cirtec Medical and Hilite International. He currently sits on the Boards of Q Holding, Dynatect Manufacturing and Cirtec Medical, and previously sat on the Boards of Quintiles and Mold-Masters.

    Prior to joining 3i, Richard was a Principal at Halyard Capital, where he invested in companies in the media, business services and communications sectors. Prior to joining Halyard, Richard was an Associate at Entrade, where he invested in technology and internet infrastructure businesses.

    Richard began his career at Security Capital's Preferred Growth Private Equity fund.

    He is actively involved in several non-profit organisations and is the Chairman of the New York Private Equity Network. Richard received a BA in Economics from Williams College.

    3i office address

    One Grand Central Place
    60 E. 42nd St, Ste 4100
    New York, NY 10165
    +1 (212) 848 1400
    +1 (212) 848 1401
  • Jake Shuster2.jpg
    Jake Shuster
    Senior Associate

    North America / Private Equity

    Jake Shuster

    Senior Associate
    North America / Private Equity
    Healthcare, Industrial  

    Jake joined 3i in 2019 as a member of its North American Private Equity team based in New York. Jake has since been involved in 3i’s investment in Q Holdings. 

    Prior to joining 3i, Jake worked as an Associate at Golden Gate Capital, where he invested in the healthcare and industrial sectors. Prior to Golden Gate, Jake was a Senior Associate Consultant at Bain & Company, the management consulting firm, and Head of FP&A at Bowery Farming, a VC-backed start-up. 

    Jake graduated Magna Cum Laude from the University of Pennsylvania.

    3i office address

    One Grand Central Place
    60 E. 42nd St, Ste 4100
    New York, NY 10165
    +1 (212) 848 1400
    +1 (212) 848 1401
  • jamie-supple.png
    Jamie Supple
    Associate Director

    UK / Private Equity

    Jamie Supple

    Associate Director
    UK / Private Equity
    Business & Technology Services, Healthcare  

    Jamie joined 3i in 2017 and is an Associate Director. He is focused on originating and executing Private Equity investments across a range of industry sectors, primarily within the UK.

    Prior to joining 3i, Jamie was an Investment Manager at Duke Street, where he focused on the services and healthcare sectors. Prior to that, he worked in the investment banking team at Hawkpoint Partners in London advising on public and private transactions across a variety of sectors.

    Jamie holds a BA in Economics from Durham University.

    3i office address

    16 Palace Street
    London SW1E 5JD
    +44 (0)20 7975 3131
    +44 (0)20 7975 3232
  • Kristina_Wiren.jpg
    Kristina Wiren
    Associate, Private Equity

    Germany / Private Equity

    Kristina Wiren

    Associate, Private Equity
    Germany / Private Equity
    Consumer, Healthcare  

    Kristina joined 3i in 2019 as an Associate in the Private Equity team based in Frankfurt.

    She focuses on the origination and execution of investments in Germany as well as in the Consumer sector. She supports 3i's investment in Luqom Group.

    Prior to joining 3i, Kristina worked as an Investment Banking analyst at ALANTRA in Germany.

    Kristina holds a Bachelor’s degree in International Business from Copenhagen Business School.

    3i office address

    OpernTurm
    Bockenheimer Landstraße 2-4
    60306 Frankfurt am Main
    +49 69 710000 0
    +49 69 710000 113

     

    Investments

Back to top